leadership
confidence high
sentiment neutral
materiality 0.60
Labcorp appoints Brian Caveney as President Early Development & Chief Medical Officer amid spin-off prep
LABCORP HOLDINGS INC.
- Brian J. Caveney appointed Executive Vice President, President Early Development & Chief Medical and Scientific Officer effective May 1, 2023.
- His base salary increased to $650,000 as part of the organizational restructuring for the planned spin-off.
- He will receive RSU and performance share awards each valued at $67,000, plus a stock option award valued at $201,000 on May 5, 2023.